Trial Profile
A double-blind, randomized study comparing intramuscular olanzapine depot with placebo in the treatment of patients with schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Jan 2012
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Acronyms HGJZ
- Sponsors Eli Lilly and Company
- 11 Jan 2012 Results published in Current Medical Research and Opinion.
- 01 May 2008 Results have been published in the Journal of Clinical Psychiatry.
- 20 Jun 2007 New trial record.